AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2007
Feb 20, 2007
29875_dirs_2007-02-20_7d07ecd2-3886-4a42-8f91-6f29bb4231df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CORP (CVS)
CIK: 0000064803
Period of Report: 2007-02-12
Reporting Person: FERDINANDI V MICHAEL (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-02-12 | Stock Unit | A | 7863 | — | Acquired | 31163 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4049 | Direct |
| Common Stock (PEP) | 4060 | Direct |
| Common Stock (Restricted) | 23826 | Direct |
| ESOP Preference Stock | 292 | Indirect |
| Common Stock | 21288 | Indirect |
Footnotes
F2: Includes dividend reinvestment shares.
F4: Reflects stock beneficially owned pursuant to issuer's ESOP Plan.
F3: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.
F1: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan.
F5: Includes dividend reinvestment shares acquired during the course of the year.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3